Marked Increase in Amphetamine-Related Emergency Department Visits and Inpatient Admissions in Toronto, Canada, 2014-2021.
comorbidity
hospitals
longitudinal studies
methamphetamine
Journal
Canadian journal of psychiatry. Revue canadienne de psychiatrie
ISSN: 1497-0015
Titre abrégé: Can J Psychiatry
Pays: United States
ID NLM: 7904187
Informations de publication
Date de publication:
04 2023
04 2023
Historique:
pubmed:
23
2
2023
medline:
25
3
2023
entrez:
22
2
2023
Statut:
ppublish
Résumé
We report emergency department and inpatient amphetamine-related trends focusing on co-occurring substance use and psychiatric diagnoses at the Centre for Addiction and Mental Health, the largest mental health teaching hospital in Canada. We describe yearly trends in amphetamine-related Centre for Addiction and Mental Health emergency department visits and inpatient admissions out of all emergency department visits and inpatient admissions between 2014 and 2021, along with proportions of concurrent substance-related admissions and mental/psychotic disorders emergency department visits and inpatient admissions among amphetamine-related contacts; joinpoint regression analyses assessed changes in amphetamine-related emergency department visits and inpatient admissions. Amphetamine-related emergency department visits rose from 1.5% in 2014 to 8.3% in 2021, with a peak of 9.9% in 2020. Amphetamine-related inpatient admissions rose from 2.0% to 8.8% in 2021, with a peak of 8.9% in 2020. Significant increasing trends in the percentage of amphetamine-related emergency department visits happened especially between the second and the fourth quarter of 2014 (quarterly percent change = + 71.4, Prevalence of amphetamine use, mostly from methamphetamine, has been increasing in Toronto as have co-occurring psychiatric disorders and opioid use. Our findings highlight the need for increases in accessible efficacious treatments for complex populations with polysubstance use and co-occurring disorders.
Sections du résumé
BACKGROUND
We report emergency department and inpatient amphetamine-related trends focusing on co-occurring substance use and psychiatric diagnoses at the Centre for Addiction and Mental Health, the largest mental health teaching hospital in Canada.
METHODS
We describe yearly trends in amphetamine-related Centre for Addiction and Mental Health emergency department visits and inpatient admissions out of all emergency department visits and inpatient admissions between 2014 and 2021, along with proportions of concurrent substance-related admissions and mental/psychotic disorders emergency department visits and inpatient admissions among amphetamine-related contacts; joinpoint regression analyses assessed changes in amphetamine-related emergency department visits and inpatient admissions.
RESULTS
Amphetamine-related emergency department visits rose from 1.5% in 2014 to 8.3% in 2021, with a peak of 9.9% in 2020. Amphetamine-related inpatient admissions rose from 2.0% to 8.8% in 2021, with a peak of 8.9% in 2020. Significant increasing trends in the percentage of amphetamine-related emergency department visits happened especially between the second and the fourth quarter of 2014 (quarterly percent change = + 71.4,
DISCUSSION
Prevalence of amphetamine use, mostly from methamphetamine, has been increasing in Toronto as have co-occurring psychiatric disorders and opioid use. Our findings highlight the need for increases in accessible efficacious treatments for complex populations with polysubstance use and co-occurring disorders.
Identifiants
pubmed: 36809914
doi: 10.1177/07067437221125302
pmc: PMC10037744
doi:
Substances chimiques
Amphetamine
CK833KGX7E
Analgesics, Opioid
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
249-256Références
Int J Drug Policy. 2016 Dec;38:16-20
pubmed: 27842249
PLoS One. 2021 May 26;16(5):e0252090
pubmed: 34038452
Community Ment Health J. 2020 Jul;56(5):959-962
pubmed: 31997123
Harm Reduct J. 2020 Feb 27;17(1):14
pubmed: 32106854
Front Psychiatry. 2022 Jan 07;12:805002
pubmed: 35069295
Australas Psychiatry. 2019 Feb;27(1):14-17
pubmed: 30382752
Drug Alcohol Depend. 2018 Apr 1;185:322-327
pubmed: 29486421
Harm Reduct J. 2017 Jul 26;14(1):50
pubmed: 28747183
Drug Alcohol Depend. 2021 Jan 1;218:108416
pubmed: 33278761
JAMA. 2020 Oct 27;324(16):1615-1617
pubmed: 32945831
JAMA Netw Open. 2019 Apr 5;2(4):e192851
pubmed: 31026029
Drug Alcohol Rev. 2017 Mar;36(2):160-170
pubmed: 27286742
Drug Alcohol Depend. 2018 Dec 1;193:14-20
pubmed: 30326396
Int J Drug Policy. 2021 May;91:103098
pubmed: 33476863
Harm Reduct J. 2012 Feb 16;9:9
pubmed: 22339847
Addict Sci Clin Pract. 2019 Apr 1;14(1):13
pubmed: 30929641
JAMA. 2020 Oct 27;324(16):1674-1677
pubmed: 32945855